Literature DB >> 20036034

A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.

Rejko Krüger1, Manu Sharma, Olaf Riess, Thomas Gasser, Christine Van Broeckhoven, Jessie Theuns, Jan Aasly, Grazia Annesi, Anna Rita Bentivoglio, Alexis Brice, Ana Djarmati, Alexis Elbaz, Matthew Farrer, Carlo Ferrarese, J Mark Gibson, Georgios M Hadjigeorgiou, Nobutaka Hattori, John P A Ioannidis, Barbara Jasinska-Myga, Christine Klein, Jean-Charles Lambert, Suzanne Lesage, Juei-Jueng Lin, Timothy Lynch, George D Mellick, Francesa de Nigris, Grzegorz Opala, Alessandro Prigione, Aldo Quattrone, Owen A Ross, Wataru Satake, Peter A Silburn, Eng King Tan, Tatsushi Toda, Hiroyuki Tomiyama, Karin Wirdefeldt, Zbigniew Wszolek, Georgia Xiromerisiou, Demetrius M Maraganore.   

Abstract

High-profile studies have provided conflicting results regarding the involvement of the Omi/HtrA2 gene in Parkinson's disease (PD) susceptibility. Therefore, we performed a large-scale analysis of the association of common Omi/HtrA2 variants in the Genetic Epidemiology of Parkinson's disease (GEO-PD) consortium. GEO-PD sites provided clinical and genetic data including affection status, gender, ethnicity, age at study, age at examination (all subjects); age at onset and family history of PD (patients). Genotyping was performed for the five most informative SNPs spanning the Omi/HtrA2 gene in approximately 2-3 kb intervals (rs10779958, rs2231250, rs72470544, rs1183739, rs2241028). Fixed as well as random effect models were used to provide summary risk estimates of Omi/HtrA2 variants. The 20 GEO-PD sites provided data for 6378 cases and 8880 controls. No overall significant associations for the five Omi/HtrA2 SNPs and PD were observed using either fixed effect or random effect models. The summary odds ratios ranged between 0.98 and 1.08 and the estimates of between-study heterogeneity were not large (non-significant Q statistics for all 5 SNPs; I(2) estimates 0-28%). Trends for association were seen for participants of Scandinavian descent for rs2241028 (OR 1.41, p=0.04) and for rs1183739 for age at examination (cut-off 65 years; OR 1.17, p=0.02), but these would not be significant after adjusting for multiple comparisons and their Bayes factors were only modest. This largest association study performed to define the role of any gene in the pathogenesis of Parkinson's disease revealed no overall strong association of Omi/HtrA2 variants with PD in populations worldwide.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036034      PMCID: PMC4724437          DOI: 10.1016/j.neurobiolaging.2009.11.021

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  26 in total

1.  Efficiency and power in genetic association studies.

Authors:  Paul I W de Bakker; Roman Yelensky; Itsik Pe'er; Stacey B Gabriel; Mark J Daly; David Altshuler
Journal:  Nat Genet       Date:  2005-10-23       Impact factor: 38.330

Review 2.  Uncertainty in heterogeneity estimates in meta-analyses.

Authors:  John P A Ioannidis; Nikolaos A Patsopoulos; Evangelos Evangelou
Journal:  BMJ       Date:  2007-11-03

3.  Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

Authors:  Demetrius M Maraganore; Mariza de Andrade; Alexis Elbaz; Matthew J Farrer; John P Ioannidis; Rejko Krüger; Walter A Rocca; Nicole K Schneider; Timothy G Lesnick; Sarah J Lincoln; Mary M Hulihan; Jan O Aasly; Tetsuo Ashizawa; Marie-Christine Chartier-Harlin; Harvey Checkoway; Carlo Ferrarese; Georgios Hadjigeorgiou; Nobutaka Hattori; Hideshi Kawakami; Jean-Charles Lambert; Timothy Lynch; George D Mellick; Spiridon Papapetropoulos; Abbas Parsian; Aldo Quattrone; Olaf Riess; Eng-King Tan; Christine Van Broeckhoven
Journal:  JAMA       Date:  2006-08-09       Impact factor: 56.272

4.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.

Authors:  T Kitada; S Asakawa; N Hattori; H Matsumine; Y Yamamura; S Minoshima; M Yokochi; Y Mizuno; N Shimizu
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

5.  Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study.

Authors:  Alexis Elbaz; Lorene M Nelson; Haydeh Payami; John P A Ioannidis; Brian K Fiske; Grazia Annesi; Andrea Carmine Belin; Stewart A Factor; Carlo Ferrarese; Georgios M Hadjigeorgiou; Donald S Higgins; Hideshi Kawakami; Rejko Krüger; Karen S Marder; Richard P Mayeux; George D Mellick; John G Nutt; Beate Ritz; Ali Samii; Caroline M Tanner; Christine Van Broeckhoven; Stephen K Van Den Eeden; Karin Wirdefeldt; Cyrus P Zabetian; Marie Dehem; Jennifer S Montimurro; Audrey Southwick; Richard M Myers; Thomas A Trikalinos
Journal:  Lancet Neurol       Date:  2006-11       Impact factor: 44.182

6.  Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism.

Authors:  Vincenzo Bonifati; Patrizia Rizzu; Marijke J van Baren; Onno Schaap; Guido J Breedveld; Elmar Krieger; Marieke C J Dekker; Ferdinando Squitieri; Pablo Ibanez; Marijke Joosse; Jeroen W van Dongen; Nicola Vanacore; John C van Swieten; Alexis Brice; Giuseppe Meco; Cornelia M van Duijn; Ben A Oostra; Peter Heutink
Journal:  Science       Date:  2002-11-21       Impact factor: 47.728

7.  Genetic variability in the mitochondrial serine protease HTRA2 contributes to risk for Parkinson disease.

Authors:  Veerle Bogaerts; Karen Nuytemans; Joke Reumers; Philippe Pals; Sebastiaan Engelborghs; Barbara Pickut; Ellen Corsmit; Karin Peeters; Joost Schymkowitz; Peter Paul De Deyn; Patrick Cras; Frederic Rousseau; Jessie Theuns; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2008-06       Impact factor: 4.878

8.  Designing candidate gene and genome-wide case-control association studies.

Authors:  Krina T Zondervan; Lon R Cardon
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

9.  Genomewide association study for susceptibility genes contributing to familial Parkinson disease.

Authors:  Nathan Pankratz; Jemma B Wilk; Jeanne C Latourelle; Anita L DeStefano; Cheryl Halter; Elizabeth W Pugh; Kimberly F Doheny; James F Gusella; William C Nichols; Tatiana Foroud; Richard H Myers
Journal:  Hum Genet       Date:  2008-11-06       Impact factor: 4.132

10.  PINK1 mutations are associated with sporadic early-onset parkinsonism.

Authors:  Enza Maria Valente; Sergio Salvi; Tamara Ialongo; Roberta Marongiu; Antonio Emanuele Elia; Viviana Caputo; Luigi Romito; Alberto Albanese; Bruno Dallapiccola; Anna Rita Bentivoglio
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

View more
  28 in total

1.  Hyperexcitable substantia nigra dopamine neurons in PINK1- and HtrA2/Omi-deficient mice.

Authors:  Matthew W Bishop; Subhojit Chakraborty; Gillian A C Matthews; Antonios Dougalis; Nicholas W Wood; Richard Festenstein; Mark A Ungless
Journal:  J Neurophysiol       Date:  2010-10-06       Impact factor: 2.714

Review 2.  Mitochondrial protein quality control in health and disease.

Authors:  Michael J Baker; Catherine S Palmer; Diana Stojanovski
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 3.  Genetics of Parkinson disease and essential tremor.

Authors:  Christian Wider; Owen A Ross; Zbigniew K Wszolek
Journal:  Curr Opin Neurol       Date:  2010-08       Impact factor: 5.710

4.  HTRA2 variations in Taiwanese Parkinson's disease.

Authors:  Chiung-Mei Chen; Chun-Hsien Wu; Chin-Hsia Hsieh; Chih-Hsin Lin; I-Cheng Chen; Yi-Chun Chen; Li-Ching Lee; Chi-Mei Lee; Yung-Che Tseng; Guey-Jen Lee-Chen; Yih-Ru Wu
Journal:  J Neural Transm (Vienna)       Date:  2013-12-12       Impact factor: 3.575

5.  Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria.

Authors:  Chin-Hsien Lin; Meng-Ling Chen; Grace Shiahuy Chen; Chun-Hwei Tai; Ruey-Meei Wu
Journal:  Hum Genet       Date:  2011-06-24       Impact factor: 4.132

6.  The Role of MicroRNAs in Patients with Amyotrophic Lateral Sclerosis.

Authors:  Efthimios Dardiotis; Athina-Maria Aloizou; Vasileios Siokas; George P Patrinos; Georgia Deretzi; Panayiotis Mitsias; Michael Aschner; Aristidis Tsatsakis
Journal:  J Mol Neurosci       Date:  2018-11-10       Impact factor: 3.444

7.  Arabidopsis AtPARK13, which confers thermotolerance, targets misfolded proteins.

Authors:  Indranil Basak; Ramavati Pal; Ketan S Patil; Aisling Dunne; Hsin-Pin Ho; Sungsu Lee; Diluka Peiris; Jodi Maple-Grødem; Mark Odell; Emmanuel J Chang; Jan Petter Larsen; Simon G Møller
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

8.  Altered enzymatic activity and allele frequency of OMI/HTRA2 in Alzheimer's disease.

Authors:  Marie Westerlund; Homira Behbahani; Sandra Gellhaar; Charlotte Forsell; Andrea Carmine Belin; Anna Anvret; Anna Zettergren; Hans Nissbrandt; Charlotta Lind; Olof Sydow; Caroline Graff; Lars Olson; Maria Ankarcrona; Dagmar Galter
Journal:  FASEB J       Date:  2010-12-16       Impact factor: 5.191

Review 9.  Mitochondrial dysfunction in genetic animal models of Parkinson's disease.

Authors:  Alzbeta Trancikova; Elpida Tsika; Darren J Moore
Journal:  Antioxid Redox Signal       Date:  2011-10-04       Impact factor: 8.401

Review 10.  Mitochondrial Quality Control Proteases in Neuronal Welfare.

Authors:  Roman M Levytskyy; Edward M Germany; Oleh Khalimonchuk
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-02       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.